On June 4-5, 2021, the company’s senior vice president, Dr. Lan Chen , was invited to participate in the "Innovative Medicine and Key Medical Technology Research Seminar" and the Medical Scientist Entrepreneur Roundtable.

The conference was hosted by the China Pharmaceutical Industry Information Center and was grandly held in the No. 1 Garden in Danyang, Jiangsu.

The conference focused on the research and development trend of innovative drugs, high-end anti-pharmaceutical research and development and industrialization, green chemical technology and optimization, innovative drug project establishment and improved innovation, etc., exchanges and discussions, breakthroughs in the development of "stuck neck" technology, and jointly enhances my country's medical industry R&D efficiency and innovation capabilities of the pharmaceutical industry chain.

Dr. Lan Chen , Senior Vice President of Chance Pharmaceuticals, made an important speech on the theme of "Pharmaceutical Engineering Thinking of Pharmaceutical Equipment" at the conference, and analyzed the relationship between pharmaceutical equipment and the development and realization of generic drugs and innovative drugs with all the participants. Put forward the new concept of "cross-border" cooperation, which aroused the resonance of experts and entrepreneurs participating in the meeting.

As a high-tech biopharmaceutical company in the clinical stage, Chance's core business focuses on the discovery, R&D, and industrialization of new drugs for diseases that seriously affect the quality of human daily life, including respiratory diseases. It has a preparation technology platform and a device (inhaler design) technology platform.

With dedication, professional technology and rigorous pharmaceutical attitude, all Chance people are practicing the dream of pharmaceutical people, and will continue to devote themselves to "bringing brand new inhaled medicines to people in need".